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Abstract
Streptococcus agalactiae (Group B streptococcus, GBS) is a leading cause of infections in neonates and an emerging
pathogen in adults. The Lancefield Group B carbohydrate (GBC) is a peptidoglycan-anchored antigen that defines this
species as a Group B Streptococcus. Despite earlier immunological and biochemical characterizations, the function of this
abundant glycopolymer has never been addressed experimentally. Here, we inactivated the gene gbcO encoding a putative
UDP-N-acetylglucosamine-1-phosphate:lipid phosphate transferase thought to catalyze the first step of GBC synthesis.
Indeed, the gbcO mutant was unable to synthesize the GBC polymer, and displayed an important growth defect in vitro.
Electron microscopy study of the GBC-depleted strain of S. agalactiae revealed a series of growth-related abnormalities:
random placement of septa, defective cell division and separation processes, and aberrant cell morphology. Furthermore,
vancomycin labeling and peptidoglycan structure analysis demonstrated that, in the absence of GBC, cells failed to initiate
normal PG synthesis and cannot complete polymerization of the murein sacculus. Finally, the subcellular localization of the
PG hydrolase PcsB, which has a critical role in cell division of streptococci, was altered in the gbcO mutant. Collectively, these
findings show that GBC is an essential component of the cell wall of S. agalactiae whose function is reminiscent of that of
conventional wall teichoic acids found in Staphylococcus aureus or Bacillus subtilis. Furthermore, our findings raise the
possibility that GBC-like molecules play a major role in the growth of most if not all beta –hemolytic streptococci.
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Introduction
Streptococcus agalactiae was first recognized as a veterinary
pathogen causing mastitis in cattle and later as a human pathogen
responsible for severe neonatal infections [1–4]. While it remains a
major cause of morbidity and mortality in infants, S. agalactiae is a
human commensal that colonizes the rectal and the vaginal
mucosa of 15–30% of women [3,5]. Rebecca Lancefield originally
defined two cell wall carbohydrate antigens in S. agalactiae: the
group B-specific antigen (GBC) common to all strains and the
capsular antigen which currently defines 10 different serotypes (Ia,
Ib, II to IX) [6]. The complex multiantennary structure of GBC
based on the arrangement of four different oligosaccharides
(rhamnose, galactose, N-acetylglucosamine, and glucitol)
(Figure 1A) was solved in a series of seminal studies at the end
of the 80’s [7,8]. More recently, the capsular polysaccharide and
the group B carbohydrate were shown to be covalently bound to
the peptidoglycan (PG) at separate sites, i.e. to N-acetylglucosa-
mine and N-acetylmuramic acid respectively [9]. Based on an
initial prediction made from genome analysis [10], a comprehen-
sive in silico reconstruction of the biosynthetic pathway of GBC was
recently proposed by Sutcliffe and coworkers [10,11]. Despite the
importance of GBC in medical microbiology, the biological role of
this surface polysaccharide is unknown and the genetic basis of its
biosynthesis was not addressed experimentally.
In Gram-positive bacteria, the cell envelope contains carbohy-
drate-based anionic polymers that play important role in extracel-
lular interactions and as scaffolds for enzymes required in cell wall
metabolism [12,13]. The two major classes of anionic polymers are
thelipoteichoicacids(LTA)associatedtotheplasmamembraneand
thewall teichoicacids (WTA)covalently anchored to the PG.WTA,
that havebeenextensivelystudied inBacillus subtilis andStaphylococcus
aureus, were reported to be essential for proper cell division and
morphology [14,15]. WTA are made of linear chains of glycerol-
phosphate in B. subtilis, or ribitol-phosphate in S. aureus, which are
attached to the C-6 of the MurNAc residues of PG via a sugar-
containing linkage unit [16]. Interestingly, there is no report of the
presence of similar type of polyAlditol phosphate WTA (pAdoP-
WTA) inthe cellwall of streptococci includingS. agalactiae[9,17,18].
Consistently, the analysis of the genome of S. agalactiae did not reveal
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involved in the biosynthesis of pAdoP-WTA in B. subtilis or S. aureus,
respectively. However, we identified a tagO/tarO orthologous gene
in all sequenced GBS strains (gbs0136 in the strain NEM316) that
could encode an enzyme catalyzing the transfer of N-acetylgluco-
samine-1-phosphate to bactoprenyl phosphate, i.e. the first step in
the WTA biosynthetic pathway [15,19]. The presence of a gene
encoding a TarO ortholog in GBS genome (thereafter named gbcO)
suggests that a cell wall-linked glycoconjugate is synthesized in GBS.
In the absenceof a recognizable pAdoP-WTAbiosyntheticpathway
inS. agalactiae,andas already proposedbySutcliffeand coworkersin
their bioinformatic analysis [11], we hypothesized a link between
gbcO and the Group B antigen biosynthesis.
Here, we report the detailed analysis of a gbcO deletion mutant of S.
agalactiae as the first GBC-depleted strain of S. agalactiae.T h eDgbcO
mutant displayed aberrant cell morphology and major cell division
defects due to i) an abnormal distribution of the sites of active PG
synthesis, ii) a marked decrease of peptidoglycan reticulation, and iii)
an improper localization of PcsB, a major streptococcal PG
hydrolase. In conclusion, our results demonstrate that GBC plays
an essential role in the streptococcal morphology and bacterial
growth and strongly suggest that this PG-anchored rhamnose-rich
anionic polysaccharide should be considered as a functional homolog
of the conventional WTA characterized in S. aureus and B. subtilis.
Results/Discussion
GbcO is required for biosynthesis of cell wall-anchored
GBC antigen
The gbcO gene of the S. agalactiae NEM316 wild-type (WT)
strain, which encodes a TagO/TarO ortholog (Figure S1), was
inactivated to investigate its role in GBC biosynthesis (Figure 1B).
As all attempts to construct an in-frame deletion mutant of gbcO
were unsuccessful, we deleted it by allelic replacement with a
promoter- and terminator-less kanamycin marker [20,21]. Thanks
to the use of this positive selection system, the strain NEM2772
(DgbcO) bearing an inactivated gbcO gene was isolated and a
complemented strain (DgbcOpTCVVgbcO) was constructed by re-
introducing a functional gbcO gene cloned onto a low-copy-
number plasmid. To validate the role of gbcO in the biosynthesis of
GBC, S. agalactiae NEM316 WT, the isogenic DgbcO mutant, and
the complemented strains were probed with a rabbit anti-GBC
polyclonal antibody [22]. Immunofluorescence microscopy (IFM)
analysis using Wheat Germ Agglutinin to label the whole bacteria
and specific GBC antiserum revealed the presence of GBC at the
surface of WT strain and its absence in the DgbcO mutant
(Figure 2A). This defect was complemented in the DgbcO mutant
transformed with the pTCVVgbcO plasmid. This result demon-
strates that gbcO restores the exposure of GBC at the bacterial
surface. Quantification of the immunofluorescence data by flow
cytometry using simple immunolabeling with the anti-GBC serum
indicated no significant differences between wild-type and
complemented strains (data not shown).
The essential role of GbcO in GBC synthesis was confirmed by
immunogold transmission electron microscopy (TEM) experi-
ments (Figure 2B). The immunolabeling electron micrographs
show the presence of GBC (black dots) at the periphery and septa
of cells of WT and complemented strains while no gold particles
were detected on gbcO mutant cells. To demonstrate that the
immuno-reactive molecule was associated to PG as it is expected
for the GBC surface antigen [9] and that the anti-GBC serum does
not cross-react with proteins, mutanolysin extracts were treated
with pronase, separated on SDS-PAGE, transferred on nitrocel-
lulose, and probed with the anti-GBC serum. As shown in
Figure 2C, the GBC signal appears as a single band in WT and
DgbcOpTCVVgbcO extracts which was absent in the DgbcO sample.
This series of experiments provided immunological evidences that
GBC was absent from the surface of the DgbcO mutant, restored in
the complemented strain, and that the GBC antiserum specifically
recognizes a non-proteinaceous material associated to the PG.
As mentioned above (see Figure 1A), the GBC molecule has a
high phosphate and rhamnose content and is likely the major
source of these two compounds in S. agalactiae envelope. Thus, to
confirm the absence of GBC in the DgbcO mutant by an alternative
approach, we performed a quantitative analysis of rhamnose and
phosphate present in the insoluble (PG-associated) cell wall
fractions of NEM316 WT, DgbcO, and complemented strains.
We also measured in the same samples the muramic acid content
originating from the PG glycan chain. The most striking result of
these analyses was the disappearance of rhamnose in the DgbcO cell
wall whereas the WT level was restored in the complemented
strain (Figure 2D). In the DgbcO sample, we also observed a
strong decrease (85%) in the phosphate content, showing that
GBC is a major phosphate source in this cellular compartment. As
the same mass was analyzed for the three strains, we determined
that the absence of GBC in the DgbcO cell wall increased the
relative amount of peptidoglycan (measured as an increased in
muramic acid) in the analyzed sample. The increase of muramic
acid in NEM2772 (DgbcO) sample showed that GBC is a major
constituent of the cell wall of S. agalactiae that represents more than
60% of the PG dry weight in WT cell wall, a value in good
agreement with previous analysis [17]. Interestingly, these values
are in good accordance with the amount of WTA present in the
cell wall of B. subtilis or S. aureus [15]. Taken together, these
Author Summary
Streptococcus agalactiae (Group B Streptococcus) is a
leading cause of sepsis (blood infection) and meningitis
(brain infection) in newborns and in adults with underlying
diseases. S. agalactiae is a Gram-positive coccus surround-
ed by a thick cell wall that acts as an exoskeleton to
guarantee resistance to mechanical stresses and mainte-
nance of cell shape. Understanding the organization and
the functioning of the cell wall is very important as this
cellular compartment is essential to bacterial physiology
and the target of many antibiotics. In this report, we have
discovered the first gene gbcO involved in the synthesis of
an abundant polysaccharide anchored to the peptidogly-
can known for many years as the Group B antigen (GBC).
We have constructed the first GBC-depleted strain of S.
agalactiae (DgbcO) that displayed important growth-
related defects due to mislocalization of peptidoglycan
synthesis and remodeling enzymes. The phenotypes of the
DgbcO mutant are similar to those observed for a DtarO
mutant of Staphylococcus aureus, tarO being involved in
the first step of the biosynthesis of wall teichoic acid
(WTA). Hence, our results strongly suggest that GBC is the
functional homolog of WTA in GBS, both being peptido-
glycan-anchored glycopolymers required for the mainte-
nance of normal growth and proper cell division. Based on
genome comparisons, we postulate that GBC-like mole-
cules with similar functions are synthesized by other
streptococcal species responsible for a variety of infectious
diseases in human and animals. These putative biosyn-
thetic pathways might constitute attractive targets for the
development of novel antimicrobial molecules.
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GbcO catalyzes the first enzymatic step of GBC synthesis.
GbcO is an UDP-GlcNAC:lipid phosphate transferase and
a functional homolog of TarO from S. aureus
The GBS DgbcO mutant displayed a slower exponential growth
rate constant in TH broth as compared to NEM316 WT
(Figure 3A). The generation times were estimated to be 48 min
for WT strain vs 138 min for the DgbcO mutant, while that of the
complemented strain was restored to the WT value. To determine
whether GbcO truly encodes an UDP-GlcNAC:lipid phosphate
transferase, we measured the growth of the three strains in the
presence of tunicamycin, a specific inhibitor of UDP-GlcNAc to
lipid-phosphate carriers transferases [EC:2.7.8.-] [23,24]. Our
underlying hypothesis being that tunicamycin should inhibit the
growth of strains expressing GbcO but not that of GbcO-defective
strain. Maximal growth rates were measured in TH broth in the
presence of increasing concentrations of tunicamycin. We
consistently observed that the relative growth rates of NEM316
WT and DgbcO complemented strains decreased by up to 70%
whereas that of the DgbcO mutant remained unaffected in the
tested antibiotic concentration range (Figure 3B). Tunicamycin
was recently used to inhibit WTA synthesis in S. aureus and the
impact of the drug on growth rate was in the same order of
magnitude as that observed for S. agalactiae [24]. Microscopic
examination of NEM316 WT cells grown in the presence of
tunicamycin showed morphological changes similar to those
resulting from deletion of gbcO (Figure S2). These results are
fully compatible with GbcO acting as an UDP-GlcNAC:lipid
phosphate transferase involved in the first step of GBC synthesis.
The sequence homology between the streptococcal GbcO and
staphylococcal TarO proteins suggests that they catalyze the same
enzymatic reaction (Figure S1). To ascertain this hypothesis, the
complementing plasmid pTCVVgbcO was introduced into the S.
aureus RN4220DtarO mutant. This complementation experiment
revealed that the morphological and Gram staining defects of the
S. aureus DtarO mutant were corrected by expression of the
streptococcal gbcO gene (Figure 4A). To prove that the
heterologous complementation of DtarO was fully functional, we
performed the extraction and analysis of WTA in the three
staphylococcal strains following established protocols [25,26]. The
results shown in Figure 4B unambiguously demonstrate WTA
production in RN4220 WT and complemented Dtar-
OpTCVVgbcO, but not in RN4220DtarO mutant. The fact that
GbcO can functionally complement TarO provides further
support for the hypothesis that GbcO is an UDP-GlcNAC:lipid
phosphate transferase. These results demonstrated that, although
the cell wall anionic polymers GBC and polyribitol WTA are
Figure 1. Structure of GBC and proposed scheme of GBC synthesis. (A) The multiantennary GBC is shown linked to an N-acetyl muramic
(NAM) moiety, a component of PG. (B) The figure depicts the first steps of GBC synthesis where GbcO is proposed to catalyze the transfer of UDP-
GlcNAc to a lipid phosphate carrier.
doi:10.1371/journal.ppat.1002756.g001
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synthesis involves the same enzymatic reaction.
Surprisingly, the Gram staining of S. agalactiae DgbcO like that of
S. aureus DtarO was abnormal, a phenotype that was corrected in
the complemented strains (Figure 4A). This serendipitous
observation showed that GBC and WTA, are directly or indirectly
involved in the retention of the crystal violet-iodine complex in the
bacterial cytoplasm and suggests that the presence of a charged
glycopolymer in the cell wall of Gram-positive bacteria rather than
the PG thickness is a major determinant of the Gram staining
procedure.
Cell morphology, septa location, and cell separation are
affected in the GBC-depleted mutant
In standing cultures, the DgbcO mutant strain tends to flocculate
rapidly (Figure 5A) and phase contrast microscopy observations
revealed the presence of large cellular aggregates instead of small
typical chains of ovococci (Figure 5B). A careful examination of
DgbcO cell clusters (Figure 5B) suggested that they each originated
from the folding of a unique chain. To confirm this observation,
we followed the growth of GBS DgbcO mutant cells in time-lapse
experiments under light microscopy. This experiment revealed
that clusters of DgbcO mutant cells arose from the growth of a
single chain that does not break whereas the WT strain forms short
individual chains (see Video S1 for NEM316 WT and Video S2
for DgbcO in supporting information). This observation indicated
that the cell separation process of S. agalactiae was strongly altered
in the absence of GBC. The cell and chain morphology of WT,
mutant, and complemented strains were then examined by
scanning electron microscopy (SEM) and transmission electron
microscopy (TEM). As expected, NEM316 WT and complement-
ed strains cells displayed regular size and were assembled in typical
ovococci chains, with septa formed in successive parallel planes
perpendicular to the chain axis (see Figure 6A, 6B and Figure
S3) [27,28]. By contrast, no regular pattern of division can be
observed for the DgbcO mutant: cells were heterogeneous both in
size and form and the septa localization seemed to occur randomly
(Figure 6A 6B; Figure S3). Furthermore, in the mutant strain,
Figure 2. GbcO is required for GBC synthesis. (A) IFM of bacteria harvested in stationary phase and labeled with anti-GBC serum and Wheat
Germ Agglutinin lectin to detect GBC (red) or PG (green), respectively. The representative views show the GBC antigen exposed at the surface of
NEM316 WT and complemented (DgbcOpTCVVgbcO) strains but not at the surface of the DgbcO mutant. (B) Immunoelectron microscopy (IEM) of
NEM316 WT, DgbcO mutant and complemented (DgbcO pTCVVgbcO) strains. The subcellular localization of GBC was analyzed using IEM on thin
sections (,100 nm) of frozen cells; labelled with anti-GBC serum and revealed with colloidal gold particles (black dots). Black dots are clearly visible
on the periphery and septa of cells of WT and complemented strains; no labeling can be detected with the DgbcO strain. (C) Immunodetection of
GBC in mutanolysin cell wall extracts obtained from cultures harvested in stationary phase. Cell wall extracts were treated with pronase, separated on
SDS-PAGE, transferred on nitrocellulose and membrane incubated with anti-GBC serum. In this experiment, the GBC-associated signal appeared as a
single band that was undetectable in DgbcO cell wall extracts. As a loading control, cell wall extracts before pronase treatment were probed with the
biotinylated MalII lectin. (D) Analysis of muramic acid, phosphate, and rhamnose content of the cell wall of WT (black bars), DgbcO (light gray bars),
and complemented (dark gray bars) strains harvested in stationary phase (see Text S1 in supporting information). For each compound the GC-MS
analysis result is presented as a percentage of the WT value. Rhamnose, the main GBC sugar, was not detected in the cell wall of the DgbcO strain.
Error bars represent 6 S.E. of two independent experiments.
doi:10.1371/journal.ppat.1002756.g002
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DgbcO mutant (circles) and DgbcOpTCVVgbcO (empty squares) strains. Cultures were performed in TH medium without antibiotics at 37uC in 96 wells
plates in triplicate. Optical densities were recorded at 600 nm in a Tecan M200 apparatus with 5 sec agitation before measure. Average values of a
typical experiment are presented. (B) Effect of various concentrations of tunicamycin on the growth rate of WT (solid squares), DgbcO (black circles)
and DgbcOpTCVVgbcO (empty squares) strains. Tunicamycin, a general inhibitor of UDP-GlcNAc:lipid phosphate carrier transferase activities, inhibits
the growth of WT and complemented strains but not that of DgbcO mutant suggesting that GbcO carries this activity. Experiments were performed in
triplicate and results are reported as a percentage of the growth rate in absence of tunicamycin. Error bars represent 6 S.E. of triplicate experiments.
doi:10.1371/journal.ppat.1002756.g003
Figure 4. GbcO functionally complement TarO of S. aureus. (A) S. agalactiae DgbcO or S. aureus DtarO strains does not take Gram staining. In
both species, the Gram staining and morphological phenotypes are restored by introduction of the plasmid pTCVVgbcO carrying a functional S.
agalactiae gbcO gene. (B) PAGE analysis of WTA extracted from S. aureus visualized with the alcyan blue-silver staining protocol. The gel shows the
production of WTA in RN4220WT (first lane), the absence of WTA in the S. aureus DtarO strain (second lane) and the restoration of the WTA synthesis
when the tarO deficiency is complemented in trans with the streptococcal gbcO gene (third lane). The arrowhead indicates the bromophenol blue
migration front.
doi:10.1371/journal.ppat.1002756.g004
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individualized explaining the abnormal growth mode observed in
time-lapse experiments.
As in many streptococcacae (25, 26), WT and complemented
strains displayed a peripheral electron dense zone (mean thickness
6.0361.07 nm) that was not observed in DgbcO cells (see arrows
in Figure 6C). This structure must not be confused with the
polysaccharide capsule of S. agalactiae that cannot be detected by
the conventional heavy metal staining procedures used here. This
cell wall structure, the function of which is unknown was named
‘‘pellicle’’ in Lactococcus lactis and, although its composition was not
formally established, its presence correlated with the synthesis of a
Figure 5. Flocculation and aggregation phenotypes of DgbcO mutant. (A) Overnight cultures showing the non-flocculating NEM316 WT and
complemented strain (DgbcOpTCVVgbcO) and the flocculating DgbcO mutant. (B) Phase contrast views illustrating the morphological switch from
small individual chains to large bacterial clusters characteristic of DgbcO mutant (Scale bar, 5 mm).
doi:10.1371/journal.ppat.1002756.g005
Figure 6. Electron microscopy imaging of NEM316 WT, DgbcO mutant, and complemented strains. Bacteria were harvested in mid-log
phase (OD600 nm=0.5), fixed, and prepared as described in Supporting Materials and Methods (see Text S1)( A) Representative views of scanning
electron microcopy analysis illustrating the morphological alterations (size, form, and cell division abnormalities) due to gbcO inactivation. (B, C)
Transmission electron microscopy views of uranyl acetate stained thin cryosections at two magnifications (see scale bars). The presence of the pellicle
(electron dense outer layer) at the surface of WT and complemented strains observed at the higher magnification is highlighted with black arrows. An
open triangle depicts the equatorial ring (EqR), a zone of active peptidoglycan synthesis seen in almost all WT and complemented cells but absent in
the DgbcO mutant cells.
doi:10.1371/journal.ppat.1002756.g006
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lactis, depletion of a cell wall associated polysaccharide in S.
agalactiae led to the disappearance of the pellicle.
Lastly, as observed with all streptococci, GBS WT and DgbcO
complemented strains exhibited equatorial rings (EqR), i.e. a cell
wall outgrowth associated to an underlying membrane invagina-
tion (see triangles in Figure 4C) where cell division (Fts
proteins) and PG synthesis (penicillin-binding proteins) machiner-
ies are assembled to prime the assembly of new wall [27]. This
structure was never observed in DgbcO mutant suggesting that the
PG structure could be altered in the absence of GBC.
Cell wall-anchored GBC is required for normal PG
structure and correct positioning of PG synthesis sites
In line with this last hypothesis, we consistently observed that
the GBS DgbcO mutant was more susceptible to mutanolysin-
induced lysis than WT cells whereas its sensitivity to lysozyme was
not affected (Figure 7A and 7B). To test further this hypothesis,
RP-HPLC separation of the PG-derived muropeptides from WT,
DgbcO mutant, and complemented strains was carried out. More
than 50 peaks were analyzed by MALDI-TOF mass spectrometry
to deduce the structure of the separated muropeptides
(Figure 7C). The chromatograms revealed that while the
monomeric forms of PG were more abundant in extracts from
the mutant strain as compared to the WT (Figure 7C middle
row), the amount of the remaining categories (dimers, trimers,
and unresolved high MW oligomers) was lower (Figure 7C
upper row). Quantitative analysis of the chromatograms
confirmed this observation and revealed that the cross-linking
index plummeted from 34% (WT and complemented strains) to
24% (DgbcO mutant) (see Table S3 in supporting information file
Text S1). The highly cross-linked PG components accumulated in
an unresolved peak eluting between 180–220 min. As the area of
the peak was strongly reduced in the DgbcO mutant, the decrease
of the PG cross-linking was likely underestimated.
To substantiate the hypothesis of an abnormal incorporation of
PG precursors in the cell wall of the DgbcO mutant, exponentially
growing bacteria were stained with fluorescent vancomycin to
label the active zone of PG synthesis [30,31]. As already observed
in S. pneumoniae R6 [31], vancomycin staining was confined mainly
to equatorial and septal regions of NEM316 WT and comple-
mented cells (Figure 7D and Figure S4 upper and lower
rows). In contrast, we observed a low intensity uniform staining
over the entire surface of DgbcO cells (Figure 7D and Figure S4
median rows). The lack of EqR (see Figure 6C) together with
the disappearance of the discrete vancomycin labeling indicated
that, in the absence of GBC, the cell wall biosynthesis machinery
was not properly located leading to a dispersed mode of PG
synthesis and to the PG cross-linking defect.
GBC deprivation leads to a mislocalization of the putative
PG hydrolase PcsB
The consequences of the inactivation of the gbcO gene on cell
morphology and division were reminiscent to those observed for a
PcsB-null mutant of S. agalactiae strain 6313 [32,33]. PcsB (protein
required for cell wall separation) is a cell surface located putative
PG hydrolase that has orthologs in all species of the Streptococ-
caceae family. This protein possesses a cysteine-histidine-depen-
dent-amidohydrolase-peptidase (CHAP) domain and is required
for proper cell wall synthesis and efficient cell separation in S.
agalactiae and other streptococci [31,33–35], suggesting that it is
involved in PG remodeling. We therefore hypothesized that GBC
deprivation could impact the localization of PcsB and the
associated PG hydrolase activity. To test this hypothesis, IFM
experiments were performed to localize PcsB on the surface of
bacterial cells harvested in the exponential phase of growth
(Figure 8). A PcsB-specific signal located in the equatorial zone of
dividing cells corresponding to the site of active PG synthesis was
observed in NEM316 WT and complemented strains. This
localization was recently observed for the orthologous PcsB
protein in Streptococcus pneumonie [36]. By contrast, no regular
labeling pattern can be distinguished in DgbcO mutant and PcsB-
associated signals were unevenly distributed on the cell surface and
in some instances accumulated in foci. This result indicates that
GBC is involved in the proper localization of PcsB, a cell wall
protein involved in bacterial division and PG biosynthesis.
These results can be paralleled to those recently reported In B.
anthracis. In this species, a tagO-like gene is implicated in the linkage
of the pyruvylated cell wall polysaccharide (SCWP) to the envelope
and the tunicamycin treatment of B. anthracis cultures alters the cell
morphology and delocalizes the PG synthesis [25]. This phenotype
can be correlated with a mislocalization of BslO, an autolysin
involved in cell separation, and whose cell wall localization is
SCWP-dependent [37].
Concluding remarks
The cell wall of S. agalactiae contains two PG anchored
polysaccharides: the capsule, a major GBS virulence factor [38–
40], and the GBC, for which we reveal an important biological
role linked to PG biosynthesis and cell division. Unencapsulated S.
agalactiae mutants could be easily constructed in vitro and they did
not display any growth or morphological defects while being
severely affected for virulence in the mouse model [40]. On the
other hand, GBC appeared to be pivotal to the S. agalactiae cell wall
organization and its absence was associated with a substantial loss
of fitness. In this study, we provide the first genetic evidence that
the synthesis of GBC is initiated by the transfer of GlcNAc
phosphate to a lipid phosphate carrier through the activity of
GbcO, a close homolog of the enzymes (TagO/TarO) catalyzing
the first step of WTA synthesis in B. subtilis or S. aureus (Figure 1B).
The growth, morphological, and division defects of the GbcO-null
S. agalactiae mutant were reminiscent of those reported in WTA-
depleted B. subtilis [41–43] and S. aureus [24]. Furthermore, the
decrease in PG cross-linking measured in NEM2772 (DgbcO) strain
was also recently observed in S. aureus TarO-null mutants [12,13].
In S. aureus, WTA depletion was associated with the delocalization
of two proteins involved in PG metabolism: the penicillin-binding
protein PBP4 involved in transpeptidation reaction [13] and the
autolysin Atl [12]. Similarly, we demonstrate that GBC-depletion
caused the mislocalization of PcsB, an important cell-wall enzyme
(Figure 8). GBC can thus be considered as a functional equivalent
of the conventional WTA’s found in B. subtilis or S. aureus.
Although the branched rhamnose-rich polysaccharidic structure of
GBC is totally different from that of pAdoP-WTA present in B.
subtilis and S. aureus, these polymers share two important
properties: first, they both display an anionic character conferred
by their high phosphate content; second, they are covalently
anchored to the PG which suggests a tight coordination of their
synthesis with that of PG. Importantly, the fitness of GBC-depleted
mutant was dramatically reduced in vitro and we observed that the
fitness of the WT strain was similarly reduced when GbcO was
inhibited with tunicamycin. These findings indicate that the GBC
biosynthesis pathway might constitute a valuable target for the
development of novel antibiotics.
The precise structure of Lancefield antigens has been
determined for GBC only. However, immunochemical and
compositional analysis of Group A, C, E, and G cell wall
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PLoS Pathogens | www.plospathogens.org 7 June 2012 | Volume 8 | Issue 6 | e1002756Figure 7. Alterations of the murein sacculus properties and of the PG synthesis in GBC-depleted cells. (A,B) Cell lysis assays:
exponentially growing cells were harvested and resuspended in PBS buffer (OD600 nm=1) containing (A) 1 mg/ml lysozyme or (B) 20 units/ml
mutanolysin. Lysis of NEM316 WT (black circles), DgbcO mutant (white squares), and DgbcOpTCVVgbcO complemented (black diamonds) strains was
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[44–48]. In these streptococcal species, the biosynthetic pathways
and biological roles of the cell wall glycopolymers have not been
investigated yet. A careful examination of the genomes of species
representative of the major streptococcal phylogenetic lineages (the
so-called pyogenic, bovis, salivarius, mutans, mitis, and anginosus
groups) revealed the presence of a gbcO ortholog together with loci
thought to be involved in the synthesis of a rhamnose-containing
exopolysaccharide, while orthologs of conventional WTA synthe-
sizing genes were not detected. This analysis suggests that PG-
anchored rhamnose-rich polysaccharides are widespread among
streptococci including important streptococcal human pathogens
(like S. agalactiae and S. pyogenes). It is likely that their function is
similar to that of GBC and inactivation of the streptococcal gbcO
orthologs constitutes a simple and straightforward approach to
validate this hypothesis.
Materials and Methods
Bacterial strains, media and growth conditions
The bacterial strains used are listed in Table S1 in Text S1. S.
agalactiae NEM316 is a ST-23 serotype III strain whose genome
has been sequenced [10]. S. agalactiae was cultured in Todd-Hewitt
(TH) broth (standing filled flasks) or agar (Difco Laboratories,
Detroit, MI) at 37uC. Escherichia coli DH5a (Invitrogen) used for
cloning experiments was grown in Luria-Bertani (LB) medium.
Erythromycin was used at 150 mg/ml for E. coli and 10 mg/ml for
S. agalactiae. E. coli strains were grown in Luria-Bertani (LB)-broth
or on LB-agar. All incubations were at 37uC. Kanamycin was used
at concentrations of 20 mg/ml and 500 mg/ml for E. coli and S.
agalactiae, respectively. Gram staining was performed using the
bioMe ´rieux Gram Stain kit according to the manufacturer’s
instructions.
GBC and PcsB detection by immunofluorescent
microscopy (IFM) assays
Cultures harvested in exponential (OD600=0.5) or stationary
phase (6-hours cultures, OD600=1.5) as indicated in legends to
figures were resuspended in PBS at OD600=1 after three PBS
washes. The bacterial suspension (50 ml) was applied on polylysine-
coated glass coverslips for 5 min at room temperature, washed
twice with PBS and fixed for 15 min with 3% paraformaldehyde.
For GBC detection, bacterial cells were harvested in stationary
phase and incubated in PBS-BSA 3% with anti-GBC rabbit serum
(1/1000) for 30 min. For PcsB detection, bacterial cells were
harvested in exponential phase and incubated with mouse serum
raised against PcsB (1:100) obtained as described in Text S1. After
three PBS washes, the coverslips were incubated with Alexa Fluor
recorded spectrophotometrically at 600 nm. Error bars represent 6 S.E. of three independent experiments (C) Comparative analysis of the
muropeptides resulting from mutanolysin-digested peptidoglycan (see Text S1) of NEM316 WT (upper panel), DgbcO (median panel), and
complemented (bottom panel) strains. Muropeptides were separated by RP-HPLC and the peaks were collected and analyzed by MALDI-TOF. (D)
Fluorescent vancomycin staining of exponentially growing NEM316 WT, DgbcO mutant and complemented strains. Fluorescent vancomycin (2 mg/
ml) was added to exponential-phase cultures for 10 min at 37uC. Cells were harvested, transferred to glass slides, fixed, and observed by fluorescent
microscopy as described in Supporting Materials and Methods (see Text S1).
doi:10.1371/journal.ppat.1002756.g007
Figure 8. Fluorescent immunolocalization of the putative peptidoglycan hydrolase PcsB. Exponentially growing NEM316 WT, DgbcO
mutant and DgbcOpTCVVgbcO complemented strains were harvested, transferred to glass slide, and fixed. IFM with anti-PcsB serum and DAPI
staining were performed as described in Materials and Methods.
doi:10.1371/journal.ppat.1002756.g008
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immunoglobulin G (IgG) (Invitrogen) (1/5000) and DAPI
(Invitrogen) (1/5000).
GBC immunodetection after SDS-PAGE and
Nitrocellulose transfer
Mutanolysin cell wall extracts were prepared from stationary
phase cultures. Bacterial pellet were washed twice in PBS and
resuspended at a final OD600 nm=100 in 50 mM Tris-HCl
(pH 7.5) containing sucrose (1 M), mutanolysin (200 U/ml)
(Sigma), and incubated for 60 min at 37uC. The suspension was
then centrifuged at 5,000 g for 15 min at 4uC. The supernatant
corresponding to the cell wall extract was collected. To improve
the resolution of the GBC band, the cell wall extracts were treated
with pronase at 2 mg/ml for 90 min at 60uC. Twenty microliters
(,2 OD units) were loaded on 12% SDS-PAGE for electropho-
resis. Transfer was performed on nitrocellulose membrane in a
semi-dry electrophoretic transfer cell (Bio-Rad) at 20 V for 20 min
in 48 mM Tris, 39 mM glycine, 20% Ethanol, pH 9.2. Mem-
brane was incubated with anti-GBC serum (1/1000) for one hour
and then with AlexaA488-conjugated Goat-anti-Rabbit IgG (1/
10,000). Membranes were scanned on a Fuji FLA-3000 fluorescent
imaging system.
Vancomycin staining
For staining, a 1:1 mixture of vancomycin and BODIPY FL
vancomycin (Invitrogen) at a final concentration of 2 mg/ml was
added to exponentially growing S. agalactiae cultures for 10 min, as
described [31]. Bacteria were harvested and washed three times
with PBS and then resuspended in PBS at OD600=1. The
bacterial suspension was then applied on coverslips and treated as
described above.
Growth conditions for electron microscopy samples
Overnight cultures of S. agalactiae were diluted (1/100) into TH
and cultivated at 37uC until OD600 nm<0.5. Samples were then
prepared for TEM, SEM, and IEM as described in supporting
information file Text S1.
Bacterial lysis assays
Bacteria were harvested in exponential phase (OD600=0.5) and
washed twice with PBS. Cells were resuspended at OD600=1in
PBS and incubated at 37uC in the presence of lysozyme (1 mg/ml)
or mutanolysin (20 units/ml). Lysis was followed by changes in
optical density at 600 nm at the indicated times.
Growth curves in the presence of tunicamycin
Growth of S. agalactiae strains in the presence of tunicamycin
(Sigma) was assayed in TH at 37uC at the following final
concentrations: 0, 0.1, 0.25, 0.5, and 2 mg/ml. Growth was
recorded in triplicates in 96-well plates in a TECAN M200 plate
reader at 600 nm. Maximal growth rates were calculated and
reported on the graph as a percentage of the growth rate in
absence of tunicamycin.
Extraction and native PAGE analysis of S. aureus WTA
The preparation of cell wall insoluble material by the SDS-
boiling procedure, followed by proteolytic digestion and base-
catalyzed (NaOH) WTA cleavage was essentially performed as
described [25] except that proteinase K was replaced by pronase
(2 mg/ml). The native PAGE analysis on T20%C6% gel system
was run as described [25]. The WTA bands were stained with the
alcyan blue-silver staining protocol using the Bio-Rad silver
staining kit as described [25].
Composition analysis of cell walls by gas
chromatography coupled to mass spectrometry
Cell walls from stationary phase cultures were prepared as
described for L. lactis [49] without HF and TCA treatments to
preserve cell wall anchored polysaccharides. Hydrolysis of cell wall
samples was performed by treatment in 4 M TFA at 110uC for
3 h, in the presence of xylose added as an internal standard. After
drying, the products of the TFA hydrolysis were resuspended in
pyridine and derivatized with N-methyl-N-(trimethyl-silyl) trifluor-
oacetamide (MSTFA) for 30 min at 25uC. The samples were then
analyzed by gas chromatography coupled to mass spectrometry
(GC-MS) with an Agilent system (GC 6890+ and MS 5973 N,
Agilent Technologies). Samples were injected with an automatic
injector (Gerstel PAL). Gas chromatography was performed on a
30 m ZB-50 column with 0.25 mm inner diameter and 0.25 mm
film thicknesses (Phenomenex). Helium was used as the carrier gas
and set at a constant flow rate of 1.5 ml/min. The temperature
program was 5 min isothermal heating at 80uC, followed by a
20uC/min oven temperature ramp to 300uC, and a final 3 min
heating at 300uC. Compounds were identified by both their
retention time and comparison of their electron ionization mass
spectra profiles with those of the NIST 05 Mass spectral library
(Scientific Instrument Services, Ringoes, NJ, USA). The quanti-
fication was done using an external standard calibration curves for
each molecule (2.5–25 nmol injected) established with the peak
area of specific ion and expressed in nmol/mg cell walls. For
purpose of clarity, the results were expressed for each compound
as percentage of wild-type values (Figure 2B). The average
NEM316 wild-type values were: 512.8 nmol/mg for phosphate,
450.5 nmol/mg for rhamnose and 215.7 nmol/mg for muramic
acid.
Purification and structural analysis of PG
S. agalactiae cell walls were prepared from exponential phase
cultures (OD600=0.5) as described previously for Lactococcus lactis
[49] and Lactobacillus plantarum [50] with the following modifica-
tion: an acidic treatment with 5% TCA was performed (24 h at
4uC) before the hydrofluoric acid treatment to remove capsular
polysaccharide [17,51].
Purified PG was digested with mutanolysin (300 U/mg PG)
from Streptomyces globisporus (Sigma-Aldrich) and the resulting
muropeptides were analyzed after NaBH4 reduction by RP-
HPLC and MALDI-TOF mass spectrometry, as previously
reported [52]. Fractions were collected and 1 ml of those
containing the main peaks were analyzed by MALDI-TOF mass
spectrometry with a Voyager DE STR mass spectrometer (Applied
Biosystems) and a-cyano-4-hydroxycinnamic acid matrix. The PG
structure of S. agalactiae belongs to the A3a group with L-Ala-D-
iGln-L-Lys-D-Ala-D-Ala as stem peptide and the dipeptides L-
Ala-L-Ala or L-Ala-L-Ser as interpeptide bridges connecting the
L-Lys of one stem peptide to the D-Ala in position 4 of the
neighbouring subunit [53]. The theoretical masses of the
muropeptides with the possible expected structural variations
were calculated. The masses determined by Maldi-Tof were then
compared with the theoretical masses to classify the HPLC-
separated muropeptides as monomers (m/z,1568), dimers
(1803,m/z,2647) or trimers (.2647). Cross-linking index (CI)
was calculated with the formula according to Glauner (1988) [54]:
CI=(1/2 Sdimers+2/3 Strimers)/S all muropeptides.
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Figure S1 Multiple sequence aligment of putative UDP-
N-GlcNAc:undecaprenyl-phosphate (UndP) GlcNAc-1-
phosphate transferases. The Swiss-Prot proteins were TagO
from B. subtlis 168 (O34753), TarO from S. aureus N315 (Q7A6R9)
and their orthologs GbcO (Gbs0136) from S. agalactiae NEM316
(Q8E7L8), RgpG from S. pyogenes SF370/M1 (Q9A1G6), and
RgpG from S. mutans UA159 (Q8CZF2). Black and grey boxes
with white letter: 100% and 80% of sequence identity,
respectively; grey box with black letter, 60% of sequence identity.
(TIF)
Figure S2 Morphological aberrations induced by tuni-
camycin. S. agalactiae NEM316 WT strain (upper row) was
cultivated in TH at 37uC with the indicated concentrations of
tunicamycin. Light microscopy imaging was performed on living
cells in stationary phase. Lower row displays an image of
NEM2772 (DgbcO) that highlights the morphological similarities
with tunicamycin-cultivated WT cells. Scale bar: 1 mm.
(TIF)
Figure S3 Scanning electron microscopy views of S.
agalactiae NEM316 WT, DgbcO mutant and comple-
mented strains. Bacteria were cultivated in TH at 37uC and
harvested in exponential phase (OD600 nm=0.5). Different fields at
three different scales (see scale bars) revealed that the DgbcO
mutant no longer display typical chains of ovococci.
(TIF)
Figure S4 Fluorescent vancomycin staining. Phase con-
trast and epifluorescence imaging of exponentially growing
bacteria labeled with DAPI (DNA marker) and fluorescent
vancomycin (marker of PG synthesis sites) as indicated in
Supporting Materials and Methods (see Text S1). (Scale bars
1 mm). The regular vancomycin labeling is lost in DgbcO strain.
(TIF)
Text S1 Contains supporting materials and methods;
table S1, table S2 and table S3 and supporting references.
(DOCX)
Video S1 Growth of NEM316 WT was performed at
376C. The elapsed time is 4.5 hours.
(AVI)
Video S2 Growth of NEM316 DgbcO mutant was
performed at 376C. The elapsed time is 6 hours.
(AVI)
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